Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Controlled Open-label Trial of Conservative Management Versus Minimally Invasive Treatment With Leukocyte- and Platelet-rich Fibrin Versus Primary Surgery in Patients With Newly Diagnosed Osteonecrosis of the Jaw

NCT04512638 is registered in ClinicalTrials.gov with Tim Van den Wyngaert as lead sponsor.

NCT NCT04512638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04512638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Controlled Open-label Trial of Conservative Management Versus Minimally Invasive Treatment With Leukocyte- and Platelet-rich Fibrin Versus Primary Surgery in Patients With Newly Diagnosed Osteonecrosis of the Jaw
Lead sponsor
Tim Van den Wyngaert
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2021
Completion date
January 1, 2026
Enrollment
125 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

medication related osteonecrosis of the jaw